ARTAL GROUP S.A. – Taysha Gene Therapies, Inc. Transaction History
ARTAL GROUP S.A. portfolio value:
$2.00M
portfolio value
ARTAL GROUP S.A. quarter portfolio value change:
-48.12%
quarter
Taysha Gene Therapies, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -1.86M | $1.93 | 1.04M | |
| Q2 2022 | share | 0.00% | 0 shares | -2.91M | $3.72 | 1.04M | |
| Q1 2022 | share | 0.00% | 0 shares | -5.33M | $6.52 | 1.04M | |
| Q4 2021 | share | 0.00% | 0 shares | -7.25M | $11.74 | 1.04M | |
| Q3 2021 | share | 0.00% | 0 shares | -2.68M | $18.62 | 1.04M | |
| Q2 2021 | share | 0.00% | 0 shares | 937K | $21.2 | 1.04M | |
| Q1 2021 | share | 0.00% | 0 shares | -6.49M | $20.3 | 1.04M | |
| Q4 2020 | share | Decrease | -8.77% | -100K shares | 2.06M | $26.54 | 1.04M |
| Q3 2020 | share | Increase | 0.00% | 1.14M shares | 25.55M | $22.4 | 1.14M |